Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
PZ HTL SA
GLOBETECH PUBLISHING

Immune System Regulator Allows Inflammatory Response While Preventing Autoimmune Attack

By BiotechDaily International staff writers
Posted on 18 Jun 2013
Image: Schematic of balance between tolerance and inflammation mediated by BACH2 (Photo courtesy of the US National Institutes of Health).
Image: Schematic of balance between tolerance and inflammation mediated by BACH2 (Photo courtesy of the US National Institutes of Health).
The BACH2 (BTB and CNC homology 1, basic leucine zipper transcription factor 2) gene was shown recently to encode for a protein that acts as a master immune system regulator by enabling inflammatory response to disease causing agents on the one hand and by preventing a hyper-inflammatory response and autoimmune attack on the other.

Genetic polymorphisms within a single locus encoding the BACH2 transcription factor are associated with numerous autoimmune and allergic diseases including asthma, Crohn’s disease, celiac disease, vitiligo, multiple sclerosis, and type I diabetes. The BACH2 protein is normally found on the surface of CD4+ T-cells. These cells play a dual role within the immune system with some populations of CD4+ T-cells activating immune responses, while others, regulatory T-cells (Tregs), function to limit immune responses. An in-depth study of how the BACH2 regulatory factor controls the balance between the two types of immune response was conducted by investigators at the [US] National Institutes of Health (Bethesda, MD, USA).

The investigators worked with a genetically engineered mouse line that permitted silencing or activation of BACH2. They found that the loss of the BACH2 gene in CD4+ T-cells caused them to become inflammatory, even in situations that would normally result in the formation of protective regulatory cells. Mice lacking the BACH2 gene generated large numbers of inflammatory cells, and the animals died of autoimmune diseases within the first few months of life. Insertion of the BACH2 gene via gene therapy into BACH2-deficient cells restored their ability to produce regulatory cells.

"Although genes have been found that play specific roles in either inflammatory cells or regulatory cells, BACH2 regulates the choice between the two cell types, resulting in its critical role in maintaining the immune system’s healthy balance," said senior author Dr. Nicholas P. Restifo, an investigator at the [US] National Institutes of Health. "It is apt that the gene shares its name with the famous composer Bach, since it orchestrates many components of the immune response, which, like the diverse instruments of an orchestra, must act in unison to achieve symphonic harmony."

The study was published in the June 2, 2013, online edition of the journal Nature.

Related Links:

[US] National Institutes of Health



Channels

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more

Business

view channel

Analytical Sciences Trade Fair Declared a Rousing Success

Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event. The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.